Chemical and Biological Studies on 1,2-Dihydro-s-triazines. IV. Activity in Pteroylglutamic Acid-Streptococcus faecaelis No. 8043 Systems
01 Aug 1953-Experimental Biology and Medicine (SAGE PublicationsSage UK: London, England)-Vol. 83, Iss: 4, pp 733-739
TL;DR: The inhibitory effect of 71 1,2-dihydro-s-tri-azines on Streptococcus faecalis No. 8043 is reversed by appropriate concentrations of dihydropteroylglutamic acid, N10-formylpteroyl glutamic Acid, synthetic and natural citrovorum factor and thymine, suggesting that these compounds interfere with the conversion of pteroyLglutomic acid to citrovoration factor.
Abstract: SummaryA series of 71 1,2-dihydro-s-tri-azines have been studied in Streptococcus faecalis No. 8 043-pteroylglutamic acid assay systems. The active derivatives exhibit noncompetitive inhibition over a wide range of concentrations of PGA and differ from 4-aminopteroylglutamic acid in that inhibition is not relieved by adenine or guanine and is irreversible with pteroylglutamic acid. Differences in microbiological activity could be correlated with certain variations in structure and substitution in the molecule with the series. Maximum activity is obtained with 2,2-dimethyl substitution in the triazine ring together with para-and meta-halogen sub-stituents in the phenyl ring. The inhibitory effect of these compounds on Streptococcus faecalis No. 8043 is reversed by appropriate concentrations of dihydropteroylglutamic acid, N10-formylpteroylglutamic acid, synthetic and natural citrovorum factor and thymine, suggesting that these compounds interfere with the conversion of pteroylglutamic acid to citrovorum fa...
Citations
More filters
TL;DR: The chapter concludes that the costly lag between discovery in the laboratory or in the clinic and application to the patient with cancer should be abolished or greatly shortened.
Abstract: Publisher Summary This chapter discusses that the consideration of the status of chemotherapy of cancer in man today is based upon the actual achievement of objective effects against several forms of disseminated cancer by the action of chemical substances. A review of the advances in cancer chemotherapy in small number of institutions, which have pioneered in this field, leaves no question concerning the value of these directions of research. The chapter explores that the panels are accelerating progress in the areas of organic chemistry, screening, pharmacology, biochemistry, and clinical investigation. Synthesis of new chemical compounds is proceeding in a number of directions, although most of the workers are making nucleic acid inhibitors and cytotoxic agents. The pharmaceutical industry and the university laboratories are furnishing thousands of chemical compounds for biological studies from their stock sources. The chapter concludes that the costly lag between discovery in the laboratory or in the clinic and application to the patient with cancer should be abolished or greatly shortened.
180 citations
TL;DR: In the six folic acid analogues there was a high degree of correlation between cytotoxicity in vitro, carcinolytic activity in vivo, acute toxicity in mice and antibacterial action in a system designed for the detection of antifolic activity, while with the remaining miscellaneous compounds there was no apparent correlation.
139 citations
TL;DR: Some novel derivatives of 1-aryl-4,6-diamino-1,2-dihydrotriazines have been synthesized using neat technology under microwaves and tested in vitro against both sensitive and resistant Plasmodium falciparum strains for antimalarial activity.
37 citations
TL;DR: Compounds of structure I are converted on oxidation to 8-aryl-8-azapurines (11)2-4, which proved to be essentially devoid of antimetabolite activity in the authors' studies.
Abstract: THE antimetabolite activity of a series of 5-arylazopyrimidines (I) has been observed in these laboratories. This type of compound, which is synthesised by the coupling of a diazotised arylamine with a 5-unsubstituted pyrimidine, has been described previ~usly~-~ but, although slight inhibition in certain bacterial systems was observed2, no specific antimetabolite activity was reported. Compounds of structure I are converted on oxidation to 8-aryl-8-azapurines (11)2-4, which proved to be essentially devoid of antimetabolite activity in our studies. This investigation began with the synthesis of new derivatives of structures I and I1
28 citations